with your 30b valuation ceiling for early 2022 buyout, you valued post 1 at preclinical and 2.5b. given it has the most potential(as per Dr T.) are we not doing it justice?
although I agree with you that we will probably not get a buyout figure that would potential be equal to the success of 3 pillars, would that mean the ultimate deal would be buyout with royalties? Would this type of deal get the most out of pillar 2/3?
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$2.58 |
Change
0.280(12.2%) |
Mkt cap ! $448.4M | |||
| Open | High | Low | Value | Volume |
| $2.45 | $2.75 | $2.42 | $3.510M | 1.351M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 10767 | $2.58 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.62 | 5000 | 1 |
View Market Depth
| Last trade - 16.10pm 17/09/2025 (20 minute delay) ? |
| RAC (ASX) Chart |